501 related articles for article (PubMed ID: 14685677)
1. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
Wasmuth HE; Lammert F; Matern S
Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.
Weber S; Gressner OA; Hall R; Grünhage F; Lammert F
Clin Liver Dis; 2008 Nov; 12(4):747-57, vii. PubMed ID: 18984464
[TBL] [Abstract][Full Text] [Related]
3. [Genome-wide association studies in hepatology].
Weber S; Grünhage F; Hall R; Lammert F
Z Gastroenterol; 2010 Jan; 48(1):56-64. PubMed ID: 20072997
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.
Hillebrandt S; Goos C; Matern S; Lammert F
Gastroenterology; 2002 Dec; 123(6):2041-51. PubMed ID: 12454860
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis: from animal models to mapping of human risk variants.
Weber SN; Wasmuth HE
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):635-46. PubMed ID: 20955966
[TBL] [Abstract][Full Text] [Related]
6. Genomics of liver fibrosis and cirrhosis.
Osterreicher CH; Stickel F; Brenner DA
Semin Liver Dis; 2007 Feb; 27(1):28-43. PubMed ID: 17295175
[TBL] [Abstract][Full Text] [Related]
7. Genetic studies to identify hepatic fibrosis genes and SNPs in human populations.
Day CP
Methods Mol Med; 2005; 117():315-31. PubMed ID: 16118460
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis and chronic viral hepatitis.
Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
[TBL] [Abstract][Full Text] [Related]
11. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C.
Richardson MM; Powell EE; Barrie HD; Clouston AD; Purdie DM; Jonsson JR
J Med Genet; 2005 Jul; 42(7):e45. PubMed ID: 15994870
[TBL] [Abstract][Full Text] [Related]
12. [Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].
Goncharova IA; Beloborodova EV; Freĭdin MB; Beloborodova EI; Chernogoriuk GE; Puzyrev VP
Mol Biol (Mosk); 2008; 42(2):238-41. PubMed ID: 18610831
[TBL] [Abstract][Full Text] [Related]
13. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
[TBL] [Abstract][Full Text] [Related]
14. Genetics of liver injury and fibrosis.
Weber SN; Lammert F
Alcohol Clin Exp Res; 2011 May; 35(5):800-3. PubMed ID: 21284669
[TBL] [Abstract][Full Text] [Related]
15. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
16. Host genetic factors influence disease progression in chronic hepatitis C.
Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR
Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535
[TBL] [Abstract][Full Text] [Related]
17. A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection.
Reynolds WF; Patel K; Pianko S; Blatt LM; Nicholas JJ; McHutchison JG
Genes Immun; 2002 Sep; 3(6):345-9. PubMed ID: 12209361
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells and the reversal of fibrosis.
Kisseleva T; Brenner DA
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
